Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding
about
Dietary fructose and glucose differentially affect lipid and glucose homeostasisFatty acids from very low-density lipoprotein lipolysis products induce lipid droplet accumulation in human monocytes.Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiencyMarkedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye diseaseMeasurement of de novo hepatic lipogenesis in humans using stable isotopes.Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivo.Postprandial apoE isoform and conformational changes associated with VLDL lipolysis products modulate monocyte inflammation.VLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation.Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies.Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal womenStudying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiencyEffects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.Plasma proteome dynamics: analysis of lipoproteins and acute phase response proteins with 2H2O metabolic labelingEffects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects.Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans.Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).Using mass measurements in tracer studies--a systematic approach to efficient modeling.Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity.Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study.Gut-liver interaction in triglyceride-rich lipoprotein metabolism.Quantitation of human peptides and proteins via MS: review of analytically validated assays.Maternal and newborn infants amino acid concentrations in obese women born themselves with normal and small for gestational age birth weight.Mass spectrometry meets the challenge of understanding the complexity of the lipoproteome: recent findings regarding proteins involved in dyslipidemia and cardiovascular disease.Role of insulin in hepatic fatty acid partitioning: emerging concepts.Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia.Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.Practical immunoaffinity-enrichment LC-MS for measuring protein kinetics of low-abundance proteinsTriglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans.Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia.Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects.Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation.Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism.A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions.Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.
P2860
Q24642206-ACB2B3CA-6E07-431E-A06B-0F662388A511Q33746478-79D5279D-CFC5-4E29-A42B-1D617EDE84B4Q33903940-D25DBA7F-AB44-4B60-A58C-4B6D4E006EF7Q34120460-57B3D8F5-B7A7-425C-9876-49BF955AF3DAQ34190285-867338E6-8109-44B9-B4E0-6FE93A11241BQ34220991-2ED066CA-026E-4439-9E0E-E0C9F975F381Q34500411-36D7F169-735D-4D2E-9062-E8CDCC74E90EQ34559824-7D144716-102A-4AD8-8643-B3C03411B088Q34640735-C9C09B26-A1FD-4A9C-BB6B-B6B7EC6EE81CQ35590298-03A5D184-2E46-4C86-A686-8BB4C3EDE849Q35590308-858BA59B-10B6-4AF2-B769-C8182E9C911CQ35747264-4BC4C720-1A81-4B92-9A6A-BAA5937B97D8Q35763409-A55FA967-05B3-484F-9775-C2B5330710B9Q35958491-69A67414-8AAF-4EDD-9048-69731E2E10D2Q36089857-209BBDF4-03EE-422E-8489-0BE07291A5ECQ36145257-DCCFFC9B-5F40-41B9-94A3-E3E85093E63CQ36489934-FF286CC4-EFF0-4515-8555-CC190765476CQ36696683-EEB169FC-C90E-4937-858E-BC2264160AEEQ37013062-E767D3C6-051C-4DAD-AB21-3F1B9C5A3A0DQ37386911-4FC631EC-F646-4CEC-906E-97A147FFB166Q37394350-D52A1198-6D75-437E-A5E8-B40F5570DED1Q37418446-A7F5A2B6-BCE4-417B-AD4A-EA843E8D5BD7Q37442575-D884AC8C-2675-479A-8ED9-F643DA4728B4Q37892758-BA83C6BB-DC37-4E52-BD7C-BE82269B7DE2Q38243345-66E3592A-C632-489D-B6B1-5FA19C1B03F1Q38297902-84D6D7A0-4367-440A-A9BF-8C8656F44C35Q38577853-EF67046B-4F5E-480E-A0D3-DF9677DC6B84Q41004209-11027CE9-0615-4702-8ADB-F86E7F3DBC5CQ41571733-0B263291-D1D4-4431-81D5-C6CB2CC3BD2AQ41571785-1DC8F60E-1614-4FC1-891C-2F8D802A71D0Q41781616-E028D9BB-CE62-4E9A-B4CB-B0686DC07536Q41916623-4DEBA5B5-BDD8-4889-B012-2D83F7C6DA00Q44138790-5FE795D2-5C9D-49B0-8D33-A95F50B2F08EQ44168307-654BA602-B857-4527-93AE-C047E5BBFA8DQ44516309-003EA656-ADEA-4575-B423-AF13C7BCD09AQ44766930-1C780F8C-3890-4BFD-984C-1E217385690AQ44919539-760FB917-2B30-4FAD-A67E-6F57164916CBQ45110889-00923C0C-B4BC-4DFE-8346-F80FAEE227E8Q46885966-1772DA44-8E2A-4C76-B8A4-8504B98DC8D9Q47893671-AB5B7E6E-4621-402B-B388-077AAE7CCC77
P2860
Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Measurement of very low densit ...... Effect of fasting and feeding
@ast
Measurement of very low densit ...... Effect of fasting and feeding
@en
Measurement of very low density and low density lipoprotein apolipoprotein
@nl
type
label
Measurement of very low densit ...... Effect of fasting and feeding
@ast
Measurement of very low densit ...... Effect of fasting and feeding
@en
Measurement of very low density and low density lipoprotein apolipoprotein
@nl
prefLabel
Measurement of very low densit ...... Effect of fasting and feeding
@ast
Measurement of very low densit ...... Effect of fasting and feeding
@en
Measurement of very low density and low density lipoprotein apolipoprotein
@nl
P2093
P2860
P356
P1476
Measurement of very low densit ...... Effect of fasting and feeding
@en
P2093
P2860
P304
P356
10.1172/JCI114507
P407
P577
1990-03-01T00:00:00Z